Pharmicell Co., Ltd. (KRX:005690)
South Korea
· Delayed Price · Currency is KRW 20,150
+350 (1.77%)
Last updated: Apr 29, 2026, 2:00 PM KST
Pharmicell Revenue
Pharmicell had revenue of 3.65B KRW in the quarter ending June 30, 2014, a decrease of -58.16%. This brings the company's revenue in the last twelve months to 23.94B, down -3.60% year-over-year. In the year 2013, Pharmicell had annual revenue of 33.41B with 200.63% growth.
Revenue (ttm)
23.94B
Revenue Growth
-3.60%
P/S Ratio
49.62
Revenue / Employee
n/a
Employees
n/a
Market Cap
1,188.08B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MEDIPOST | 73.66B |
| GI Innovation | 5.84B |
| Onconic Therapeutics | 53.39B |
| Chabiotech | 1,268.25B |
| Medy-Tox | 247.29B |
| Orum Therapeutics | 23.56M |
| GC Corp. | 2,451.48B |
| SillaJen | 9.23B |